2020
DOI: 10.1016/j.vascn.2020.106932
|View full text |Cite
|
Sign up to set email alerts
|

Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 89 publications
1
12
0
Order By: Relevance
“…The applicability of transgenic C. elegans to study proteotoxicity-related diseases, such as AD and PD, has been highlighted previously (Liu et al, 2015;Paul et al, 2020). In this study, three transgenic C. elegans strains were used as models: (1) Strain CL2659 expressing Aβ in muscle cells shows a paralysis phenotype after 48 h at 25 • C and was applied to study treatments that encounter soluble Aβ oligomerization leading to a delayed onset of the paralyzed phenotype.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The applicability of transgenic C. elegans to study proteotoxicity-related diseases, such as AD and PD, has been highlighted previously (Liu et al, 2015;Paul et al, 2020). In this study, three transgenic C. elegans strains were used as models: (1) Strain CL2659 expressing Aβ in muscle cells shows a paralysis phenotype after 48 h at 25 • C and was applied to study treatments that encounter soluble Aβ oligomerization leading to a delayed onset of the paralyzed phenotype.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, the drug discovery paradigm has shifted from single-target pharmacology to the recognition and utilization of multitarget pharmacology, whereby clinical activity is expressed as the sum of several pharmacodynamic effects on multiple targets ( Chaudhari et al, 2017 ). With increasing knowledge of drug–target interactions, more effective drugs, which modulate multiple targets, might be discovered for diseases such as PD and AD ( Wang et al, 2019 ; Mok et al, 2020 ; Paul et al, 2020 ; Zagórska and Jaromin, 2020 ; Albertini et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Transgenic C . elegans that expressed human Aβ 1‐42 or Tau have been constructed and used for screening anti‐AD drug, identifying the underlying molecular mechanism of the compounds and revealing the pathogenesis of AD 8‐10 …”
Section: Introductionmentioning
confidence: 99%
“…Transgenic C. elegans that expressed human Aβ 1-42 or Tau have been constructed and used for screening anti-AD drug, identifying the underlying molecular mechanism of the compounds and revealing the pathogenesis of AD. [8][9][10] Traditional Chinese medicine Polygalae Radix (Yuanzhi, Root of Polygala tenuifolia Willd.) has the efficacies of tranquillizing mind and improving the intelligence, which is often used for insomnia and amnesia.…”
mentioning
confidence: 99%
“…Currently, the mammalian as an in vivo model for the selection of anti-AD drug candidates has some limitations, including the cost and time of the experiment and the number and quality of the study subjects (Alexander et al, 2014). In addition, mammalian neuronal cell culture in vitro cannot completely simulate the complexities of the human brain (Paul et al, 2020). Therefore, it is necessary to explore alternative experimental models for screening anti-AD drugs.…”
Section: Introductionmentioning
confidence: 99%